A nuclear matrix antigen HeLa and other human malignant cells

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Chromatin, the complex of DNA and proteins that forms chromosomes, plays a crucial role in cellular processes.
• Identifying specific antigens within chromatin can aid in understanding cellular function and disease states.
• Dehistonized chromatin preparations from cell lines like HeLa are often used to generate specific antibodies.

Purpose of the Study:

• To generate and characterize antisera against dehistonized HeLa cell chromatin.
• To identify specific protein antigens within human chromatin, particularly those differentially expressed in tumors.
• To investigate the cellular localization of identified tumor-associated antigens.

Main Methods:

• Production of antisera in rabbits against dehistonized HeLa cell chromatin.
• Complement fixation assays to determine antiserum reactivity with different chromatin preparations.
• Immunochemical staining of electrophoretically separated proteins (Western blotting) and immunoabsorption techniques.
• Cellular fractionation to isolate cytoplasmic and nuclear components.

Main Results:

• Antisera reacted strongly with HeLa cell chromatin but minimally with human placenta chromatin.
• Immunochemical analysis revealed numerous chromatin antigens in tumors, placenta, and kidney, with one major 81,000 MW protein antigen unique to tumors.
• This 81,000 MW tumor-associated antigen was localized to the nuclear matrix fraction.

Conclusions:

• A specific nuclear matrix protein antigen (81,000 MW) is highly expressed in human tumors and absent in normal tissues like placenta and kidney.
• This tumor-specific antigen represents a potential biomarker for cancer detection or therapeutic targeting.
• The generated antisera are valuable tools for immunochemical studies of chromatin structure and composition.